The current study was designed to evaluate the effects of silymarin (SM) on advanced glycation endproduct (AGE) formation and monocyte activation induced by S100b, a specific ligand of receptor for AGEs. The in vivo verification of antiglycation, antioxidant, and antiinflammatory capacities was examined by 12 weeks of SM administration in streptozotocin-diabetic rats. In vitro glycation assays demonstrated that SM exerted marked inhibition during the late stages of glycation and subsequent crosslinking. Dual action mechanisms, namely, antioxidant and reactive carbonyl trapping activities, may contribute to its antiglycation effect. SM produced a significant decrease in monocytic interleukin-1β and COX-2 levels and prevented oxidant formation caused by S100b, which appeared to be mediated by inhibition of p47phox membrane translocation. Chromatin immunoprecipitation demonstrated that S100b increased the recruitment of nuclear factor-kappaB transcription factor as well as cAMP response element-binding–binding protein and coactivator-associated arginine methyltransferase-1 cofactors to the interleukin-1β promoter, whereas these changes were inhibited with SM treatment. In vivo, SM reduced tissue AGE accumulation, tail collagen crosslinking, and concentrations of plasma glycated albumin. Levels of oxidative and inflammatory biomarkers were also significantly decreased in SM-treated groups compared with the diabetic group. These data suggest that SM supplementation may reduce the burden of AGEs in diabetics and may prevent resulting complications. Antioxid. Redox Signal. 14, 353–366.
Get full access to this article
View all access options for this article.
References
1.
Bonnefont-RousselotD. Antioxidant and anti-AGE therapeutics: evaluation and perspectives. J Soc Bio, 195:391–398. 2001.
2.
Bonnefont-RousselotD. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care, 5:561–568. 2002.
3.
CohenMP. Intervention strategies to prevent pathogenetic effects of glycated albumin. Arch Biochem Biophys, 419:25–30. 2003.
4.
DasuMR, DevarajS, JialalI. High glucose induces IL-1beta expression in human monocytes: mechanistic insights. Am J Physiol Endocrinol Metab, 293:E337–E346. 2007.
5.
DayJF, ThorpeSR, BaynesJW. Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum. J Biol Chem, 254:595–597. 1979.
6.
DevarajS, VenugopalSK, SinghU, JialalI. Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase C-α and -βDiabetes, 54:85–91. 2005.
7.
DonatoR. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med, 7:711–724. 2007.
8.
FigarolaJL, LoeraS, WengY, ShanmugamN, NatarajanR, RahbarS. LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat. Diabetologia, 51:882–891. 2008.
9.
FigarolaJL, ShanmugamN, NatarajanR, RahbarS. Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes. Diabetes, 56:647–655. 2007.
10.
FinottiP, PagettaA, AshtonT. The oxidative mechanism of heparin interferes with radical production by glucose and reduces the degree of glycooxidative modifications on human serum albumin. Eur J Biochem, 268:2193–2200. 2001.
11.
ForbesJM, CooperME, ThallasV, BurnsWC, ThomasMC, BrammarGC, LeeF, GrantSL, BurrellLA, JerumsG, OsickaTM. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes, 51:3274–3282. 2002.
12.
GuhaM, BaiW, NadlerJL, NatarajanR. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem, 275:17728–17739. 2000.
13.
HayashiT, OhtaY, NamikiM. Electron spin resonance spectral study on the structure of the novel free radical products formed by the reactions of sugars with amino acids or amines. J Agric Food Chem, 25:1282–1287. 1977.
14.
HipkissAR, BrownsonC, CarrierMJ. Carnosine the anti-ageing anti-oxidant dipeptide may react with protein carbonyl groups. Mech Ageing Dev, 122:1431–1445. 2001.
15.
HortelanoS, DewezB, GenaroAM, Díaz-GuerraMJ, BoscáL. Nitric oxide is released in regenerating liver after partial hepatectomy. Hepatology, 21:776–786. 1995.
16.
HussainSA. Silymarin as an adjunct to glibenclamide therapy improves long-term and postprandial glycemic control and body mass index in type 2 diabetes. J Med Food, 10:543–547. 2007.
17.
KhalifahRG, ChenY, WassenbergJJ. Post-Amadori AGE inhibition as a therapeutic target for diabetic complications: a rational approach to second-generation Amadorin design. Ann NY Acad Sci, 1043:793–806. 2005.
18.
KihoT, UsuiS, HiranoK, AizawaK, InakumaT. Tomato paste fraction inhibiting the formation of advanced glycation end-products. Biosci Biotechnol Biochem, 68:200–205. 2004.
19.
LeeC, YimMB, ChockPB, YimHS, KangSO. Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation. J Biol Chem, 273:25272–25278. 1998.
20.
LiY, ReddyMA, MiaoF, ShanmugamN, YeeJK, HawkinsD, RenB, NatarajanR. Role of the histone H3 lysine 4 methyltransferase SET7/9 in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J Biol Chem, 283:26771–26781. 2008.
21.
ManuelY, KeenoyB, VertommenJ, De LeeuwI. The effect of flavonoid treatment on the glycation and antioxidant status in Type 1 diabetic patients. Diabetes Nutr Metab, 12:256–263. 1999.
MiaoF, GonzaloIG, LantingL, NatarajanR. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J Biol Chem, 279:18091–18097. 2004.
24.
MiaoF, LiS, ChavezV, LantingL, NatarajanR. Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17. Mol Endocrinol, 20:1562–1573. 2006.
25.
MizutaniK, IkedaK, NishikataT, YamoriY. Phytoestrogens attenuate oxidative DNA damage in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Hypertens, 18:1833–1840. 2000.
26.
MontonenJ, KnektP, JarvinenR, ReunanenA. Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care, 27:362–366. 2004.
27.
MünchG, KeisR, WesselsA, RiedererP, BahnerU, HeidlandA, NiwaT, LemkeHD, SchinzelR. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem, 35:669–677. 1997.
28.
NagarajRH, ShipanovaIN, FaustFM. Protein cross-linking by the Maillard reaction: Isolation characterization and in vivo detection of a lysine-lysine cross-link derived from methylglyoxal. J Biol Chem, 271:19338–19345. 1996.
NakagawaT, YokozawaT, TerasawaK, ShuS, JunejaLR. Protective activity of green tea against free radical- and glucose-mediated protein damage. J Agric Food Chem, 50:2418–2422. 2002.
31.
Negre-SalvayreA, SalvayreR, AugéN, PamplonaR, Portero-OtínM. Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal, 11:3071–3109. 2009.
32.
RahbarS, YerneniKK, ScottS, GonzalesN, LalezariI. Novel inhibitors of advanced glycation endproducts (part II)Mol Cell Biol Res Commun, 3:360–366. 2000.
33.
RichardLR, LloydRV. Free radical formation from secondary amines in the Maillard reaction. J Agric Food Chem, 45:2413–2418. 1997.
34.
SchiekoferS, AndrassyM, ChenJ, RudofskyG, SchneiderJ, WendtT, StefanN, HumpertP, FritscheA, StumvollM, SchleicherE, HäringHU, NawrothPP, BierhausA. Acute hyperglycemia causes intracellular formation of CML and activation of ras p42/44 MAPK and nuclear factor kappaB in PBMCs. Diabetes, 52:621–633. 2003.
35.
ShanmugamN, KimYS, LantingL, NatarajanR. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J Bio Chem, 278:34834–34844. 2003.
36.
ShanmugamN, ReddyMA, GuhaM, NatarajanR. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes, 52:1256–1264. 2003.
37.
ShihPH, YehCT, YenGC. Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis. J Agric Food Chem, 55:9427–9435. 2007.
38.
ThornalleyPJ, LangborgA, MinhasHS. Formation of glyoxal methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J, 344:109–116. 1999.
39.
ThornalleyPJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch Biochem Biophys, 419:31–40. 2003.
40.
VenugopalSK, DevarajS, YangT, JialalI. Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes, 51:3049–3054. 2002.
41.
WolffSP, DeanRT. Glucose autoxidation and protein modification. Biochem J, 245:243–250. 1987.
42.
WoodsideJV, YarnellJW, McMasterD, YoungIS, HarmonDL, McCrumEE, PattersonCC, GeyKF, WhiteheadAS, EvansA. Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind randomized factorial-design controlled trial. Am J Clin Nutr, 67:858–866. 1998.
43.
WuCH, YenGC. Inhibitory effect of naturally occurring flavonoids on advanced glycation endproducts formation. J Agric Food Chem, 53:3167–3173. 2005.
44.
WuCH, HsiehCL, SongTY, YenGC. Inhibitory effects of Cassia tora L. on benzo[a]pyrene-mediated DNA damage toward HepG2 cells. J Agric Food Chem, 49:2579–2586. 2001.
45.
WuCH, WuCF, HuangHW, JaoYC, YenGC. Naturally occurring flavonoids attenuate high glucose-induced expression of proinflammatory cytokines in human monocytic THP-1 cells. Mol Nutr Food Res, 53:984–995. 2009.
46.
WuCH, YehCT, ShihPH, YenGC. Dietary phenolic acids attenuate multiple stages of protein glycation and high-glucose-stimulated proinflammatory IL-1beta activation by interfering with chromatin remodeling and transcription in monocytes. Mol Nutr Food Res, 54:1–14. 2010.
47.
WuJW, LinLC, TsaiTH. Drug-drug interactions of silymarin on the perspective of pharmacokinetics. J Ethnopharmacol, 121:185–193. 2009.
48.
YueDK, McLennanS, DelbridgeL, HandelsmanDJ, ReeveT, TurtleJR. The thermal stability of collagen in diabetic rats: correlation with severity of diabetes and non-enzymatic glycosylation. Diabetologia, 24:282–285. 1983.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
